81 F
New York
Saturday, July 2, 2022

Amyris [NASDAQ: AMRS] Declares Pricing of Public Offering of Common Stock

Must read

Amyris, Inc.  [NASDAQ: AMRS] declared that it has commenced the proposed underwritten public offering of shares of its common stock. It has disclosed that is carrying a resale of its stock on behalf of its existing shareholders. The selling shareholders are DSM International B.V. and affiliates of Vivo Capital LLC.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The selling stockholders are planning to propose a total of $150.0 million of shares of Amyris’s common stock. Moreover, AMRS is also planning to propose $100.0 million of shares of its common stock in order to assist its continuing development.

Benefit for Underwriters

Amyris has revealed that it has decided to offer the underwriters a 30-day choice to buy up to an extra $37.5 million of shares of common stock of Amyris at the public offering price, deducting underwriting markdowns and expenses. The offer of the firm is dependent on certain markets and other circumstances. The firm has not guaranteed the exact closure date of the offering.

Furthermore, Amyris has not declared the real size and terms of the suggested offering.  The joint book-running manager for the offering is Cowen and Company, LLC, and J.P. Morgan Securities LLC. Additionally, AMRS disclosed that it will not get any profit from the sale of offering by the selling shareholders.

More articles

Latest article



Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam